{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:25:19Z","timestamp":1746339919492},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FWO Flanders"},{"DOI":"10.13039\/501100001645","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejim.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T05:46:49Z","timestamp":1436420809000},"page":"461-467","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes"],"prefix":"10.1016","volume":"26","author":[{"given":"V.","family":"Thijs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2015.06.008_bb0005","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2015.06.008_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2015.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","author":"Hart","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","article-title":"Silent brain infarcts: a systematic review","volume":"6","author":"Vermeer","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/qjmed\/hct129","article-title":"Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review","volume":"106","author":"Udompanich","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2015.06.008_bb0035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(07)70291-0","article-title":"Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study","volume":"6","author":"Seshadri","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0040","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/STROKEAHA.108.540112","article-title":"Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors","volume":"40","author":"Andersen","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0045","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics-2015 update: a report from the american heart association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.06.008_bb0050","series-title":"23rd European Stroke Conference","article-title":"Rationale, Objectives and Design of a Secondary Stroke Prevention Study of Dabigatran Etexilate Versus Acetylsalicylic Acid in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)","author":"Diener","year":"2014"},{"key":"10.1016\/j.ejim.2015.06.008_bb0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0060","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","article-title":"Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010","volume":"383","author":"Feigin","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.06.008_bb0075","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0080","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2015.06.008_bb0085","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.06.008_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.06.008_bb0095","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0100","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.06.008_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1160\/TH05-02-0093","article-title":"Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease","volume":"94","author":"Freestone","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2015.06.008_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.STR.32.3.803","article-title":"Atrial fibrillation and stroke: concepts and controversies","volume":"32","author":"Hart","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2015.06.008_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000286342","article-title":"Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke","volume":"29","author":"Potter","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2015.06.008_bb0125","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.STR.0000020841.74704.5B","article-title":"Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging","volume":"33","author":"Gerraty","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0130","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/STROKEAHA.110.611376","article-title":"Acute perfusion and diffusion abnormalities predict early new MRI lesions 1 week after minor stroke and transient ischemic attack","volume":"42","author":"Asdaghi","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000210433","article-title":"New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke","volume":"27","author":"Amarenco","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2015.06.008_bb0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/STROKEAHA.109.558809","article-title":"Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy?","volume":"41","author":"Jackson","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.0b013e31828f1828","article-title":"Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke","volume":"80","author":"Cotter","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2015.06.008_bb0150","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0155","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.06.008_bb0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0170","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.06.008_bb0175","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/bmj.305.6867.1460","article-title":"Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)","volume":"305","author":"Sandercock","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2015.06.008_bb0180","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0185","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ehj.2004.06.030","article-title":"Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry","volume":"25","author":"Steger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2015.06.008_bb0190","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ehj.2004.08.005","article-title":"More bad news about atrial fibrillation","volume":"25","author":"Thijs","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2015.06.008_bb0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(06)70536-1","article-title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study","volume":"5","author":"O'Donnell","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0200","series-title":"22nd European Stroke Conference","article-title":"Recurrent events and mortality among atrial fibrillation patients treated with dabigatran or warfarin in the RELY trial","author":"Diener","year":"2013"},{"key":"10.1016\/j.ejim.2015.06.008_bb0205","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1538-7836.2012.04635.x","article-title":"Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis","volume":"10","author":"Warkentin","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2015.06.008_bb0210","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","article-title":"Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses","volume":"26","author":"Hart","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/STROKEAHA.112.650614","article-title":"Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial","volume":"43","author":"Hart","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0220","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archneur.57.12.1710","article-title":"Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk","volume":"57","author":"Phan","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0225","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.06.008_bb0230","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.STR.0000078311.18928.16","article-title":"Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis","volume":"34","author":"Eckman","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2015.06.008_bb0235","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.06.008_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(13)70079-6","article-title":"Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Whiteley","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2015.06.008_bb0245","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515002150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515002150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T03:54:49Z","timestamp":1691812489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515002150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0953620515002150"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.06.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}